1. Home
  2. RGC vs DHI Comparison

RGC vs DHI Comparison

Compare RGC & DHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGC
  • DHI
  • Stock Information
  • Founded
  • RGC 2014
  • DHI 1978
  • Country
  • RGC Hong Kong
  • DHI United States
  • Employees
  • RGC N/A
  • DHI N/A
  • Industry
  • RGC Medicinal Chemicals and Botanical Products
  • DHI Homebuilding
  • Sector
  • RGC Health Care
  • DHI Consumer Discretionary
  • Exchange
  • RGC Nasdaq
  • DHI Nasdaq
  • Market Cap
  • RGC 38.6B
  • DHI 44.8B
  • IPO Year
  • RGC 2021
  • DHI 1992
  • Fundamental
  • Price
  • RGC $13.46
  • DHI $154.92
  • Analyst Decision
  • RGC
  • DHI Buy
  • Analyst Count
  • RGC 0
  • DHI 15
  • Target Price
  • RGC N/A
  • DHI $164.50
  • AVG Volume (30 Days)
  • RGC 780.3K
  • DHI 5.1M
  • Earning Date
  • RGC 06-30-2025
  • DHI 07-22-2025
  • Dividend Yield
  • RGC N/A
  • DHI 1.03%
  • EPS Growth
  • RGC N/A
  • DHI N/A
  • EPS
  • RGC N/A
  • DHI 12.48
  • Revenue
  • RGC N/A
  • DHI $34,575,200,000.00
  • Revenue This Year
  • RGC N/A
  • DHI N/A
  • Revenue Next Year
  • RGC N/A
  • DHI $1.43
  • P/E Ratio
  • RGC N/A
  • DHI $12.41
  • Revenue Growth
  • RGC N/A
  • DHI N/A
  • 52 Week Low
  • RGC $0.09
  • DHI $110.44
  • 52 Week High
  • RGC $83.60
  • DHI $199.85
  • Technical
  • Relative Strength Index (RSI)
  • RGC 44.79
  • DHI 67.87
  • Support Level
  • RGC $12.76
  • DHI $141.07
  • Resistance Level
  • RGC $13.77
  • DHI $148.09
  • Average True Range (ATR)
  • RGC 1.35
  • DHI 4.37
  • MACD
  • RGC 0.08
  • DHI 0.90
  • Stochastic Oscillator
  • RGC 12.40
  • DHI 90.68

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

About DHI D.R. Horton Inc.

With operations in 126 markets across 36 states D.R. Horton is the leading homebuilder in the United States. D.R. Horton mainly builds single-family detached homes (87% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.

Share on Social Networks: